Search research articles
Contact Us
Filters
Showing results (31-40 of 334) with videos related to
Page
of 34
Sort By:
Expert Opinion on Biological Therapy
|
February 8, 2022
Immune checkpoint inhibitors for the treatment of melanoma
Francesco Sabbatino, Luigi Liguori, Stefano Pepe, et al.
Expert Opinion on Therapeutic Targets
|
July 21, 2015
Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors
Yangyang Wang, Claudia Geldres, Soldano Ferrone, et al.
Immunologic Research
|
October 20, 2005
Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance
Robert L Ferris, Jennifer L Hunt, Soldano Ferrone
Methods in Molecular Biology (Clifton, N.J.)
|
November 22, 2013
Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma
Yangyang Wang, Francesco Sabbatino, Xinhui Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape
Robert L Ferris, Elizabeth M Jaffee, Soldano Ferrone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Peptide and dendritic cell vaccines
Craig L Slingluff, Victor H Engelhard, Soldano Ferrone
Trends in Cancer
|
September 7, 2021
HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy
Luke Maggs, Ananthan Sadagopan, Ali Sanjari Moghaddam, et al.
Trends in Molecular Medicine
|
November 7, 2008
The complex role of B7 molecules in tumor immunology
Barbara Seliger, Francesco M Marincola, Soldano Ferrone, et al.
Cellular and Molecular Life Sciences : CMLS
|
November 11, 2010
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse-Wilde, et al.
Journal of the American Academy of Dermatology
|
March 27, 2012
HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?
Michael Campoli, James E Fitzpatrick, Whitney High, et al.
Page
of 34
Search research articles
Search
Showing results (31-40 of 334) with videos related to
Sort By:
Page
of 34
Expert Opinion on Biological Therapy
|
February 8, 2022
Immune checkpoint inhibitors for the treatment of melanoma
Francesco Sabbatino, Luigi Liguori, Stefano Pepe, et al.
Expert Opinion on Therapeutic Targets
|
July 21, 2015
Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors
Yangyang Wang, Claudia Geldres, Soldano Ferrone, et al.
Immunologic Research
|
October 20, 2005
Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance
Robert L Ferris, Jennifer L Hunt, Soldano Ferrone
Methods in Molecular Biology (Clifton, N.J.)
|
November 22, 2013
Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma
Yangyang Wang, Francesco Sabbatino, Xinhui Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape
Robert L Ferris, Elizabeth M Jaffee, Soldano Ferrone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Peptide and dendritic cell vaccines
Craig L Slingluff, Victor H Engelhard, Soldano Ferrone
Trends in Cancer
|
September 7, 2021
HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy
Luke Maggs, Ananthan Sadagopan, Ali Sanjari Moghaddam, et al.
Trends in Molecular Medicine
|
November 7, 2008
The complex role of B7 molecules in tumor immunology
Barbara Seliger, Francesco M Marincola, Soldano Ferrone, et al.
Cellular and Molecular Life Sciences : CMLS
|
November 11, 2010
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse-Wilde, et al.
Journal of the American Academy of Dermatology
|
March 27, 2012
HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?
Michael Campoli, James E Fitzpatrick, Whitney High, et al.
Page
of 34